Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units
Abstract First‐time‐in‐human (FTIH) trials are designed to generate information on the safety, tolerability, as well as the pharmacokinetic and pharmacodynamics profile of new drugs. To ensure the safety of participants, these trials need to be conducted at specifically equipped phase I clinical tri...
Main Authors: | Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad‐Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia, the ERA4TB Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13655 |
Similar Items
-
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data
by: Paloma Moraga Alapont, et al.
Published: (2023-12-01) -
Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance Program.
by: Raúl Muñoz, et al.
Published: (2016-01-01) -
Academia as Workplace
by: Mills, D, et al.
Published: (2012) -
Scientometrics and academia
by: Enver Zerem, et al.
Published: (2024-03-01) -
Evaluating Academia.
by: Barak Kalir, et al.
Published: (2010-07-01)